http://purl.org/np/RA22n5Rn32... RA22n5Rn32

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

Leoni Bücken

2021-06-29T06:58:38.963Z

http://purl.org/np/RA22n5Rn32... RA22n5Rn32

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/DOID_1406 DOID_1406

Leoni Bücken

2021-06-29T06:58:38.963Z

http://purl.org/np/RA22n5Rn32... RA22n5Rn32

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/association_type association_type

https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation

Leoni Bücken

2021-06-29T06:58:38.963Z

http://purl.org/np/RA22n5Rn32... RA22n5Rn32

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

Leoni Bücken

2021-06-29T06:58:38.963Z

http://purl.org/np/RA22n5Rn32... RA22n5Rn32

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://identifiers.org/drugbank:DB00860 drugbank:DB00860

Leoni Bücken

2021-06-29T06:58:38.963Z

http://purl.org/np/RA22n5Rn32... RA22n5Rn32

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://schema.org/TreatmentIndication TreatmentIndication

Leoni Bücken

2021-06-29T06:58:38.963Z

http://purl.org/np/RA22n5Rn32... RA22n5Rn32

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

Leoni Bücken

2021-06-29T06:58:38.963Z

http://purl.org/np/RA22n5Rn32... RA22n5Rn32

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

prednisolone sodium phosphate ophthalmic solution 1 or 1 8 is for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva cornea and anterior segment of the globe such as allergic conjunctivitis acne rosacea superficial punctate keratitis herpes zoster keratitis iritis cyclitis selected infective conjunctivitis when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation corneal injury from chemical radiation or thermal burns or penetration of foreign bodies prednisolone sodium phosphate ophthalmic solution 1 is recommended for moderate to severe inflammations particularly when unusually rapid control is desired in stubborn cases of anterior segment eye disease systemic adrenocortical hormone therapy may be required when deeper ocular structures are involved systemic therapy is necessary

Leoni Bücken

2021-06-29T06:58:38.963Z